VR
NASDAQ · VRAX
Virax Biolabs Group Limited
Healthcare · Biotechnology
$1.45
Down-$0.17 (-10.50%)
Updated Oct 18, 2026, 2:35 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.92M
- P/E ratio
- -0.37
- Dividend yield
- 0.00%
- 52-week range
- $0.10 – $13.19
- Volume
- 40.63K
- Avg. volume
- 5.08M
Price performance · VRAX
VRAX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 16, 2026
VRAX closed at $1.45 after 20 trading sessions, down 37.23% for the selected period.
- Last close
- $1.45
- Period change
- -37.23%
- Period low
- $1.45
- Period high
- $2.55
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | $1.62 | $1.64 | $1.38 | $1.45 | 40.63K |
| Oct 15, 2026 | $1.66 | $1.76 | $1.55 | $1.6202 | 44.19K |
| Oct 14, 2026 | $1.77 | $1.78 | $1.61 | $1.65 | 38.75K |
| Oct 13, 2026 | $1.80 | $1.86 | $1.7201 | $1.7381 | 43.75K |
| Oct 12, 2026 | $1.81 | $1.8999 | $1.78 | $1.85 | 71.26K |
| Oct 9, 2026 | $1.92 | $1.94 | $1.81 | $1.87 | 88.54K |
| Oct 8, 2026 | $2.13 | $2.13 | $1.93 | $1.99 | 50.79K |
| Oct 7, 2026 | $2.02 | $2.18 | $1.83 | $2.11 | 276.36K |
| Oct 6, 2026 | $2.33 | $2.33 | $1.83 | $2.03 | 311.08K |
| Oct 5, 2026 | $2.53 | $3.34 | $2.16 | $2.40 | 2.9M |
| Oct 2, 2026 | $2.21 | $2.25 | $2.13 | $2.20 | 19.61K |
| Oct 1, 2026 | $2.18 | $2.374 | $2.18 | $2.24 | 30.88K |
| Sep 30, 2026 | $2.25 | $2.27 | $2.13 | $2.184 | 19.47K |
| Sep 29, 2026 | $2.27 | $2.395 | $2.04 | $2.23 | 97.11K |
| Sep 28, 2026 | $2.35 | $2.35 | $2.30 | $2.3144 | 5.56K |
| Sep 25, 2026 | $2.38 | $2.60 | $2.38 | $2.395 | 13.43K |
| Sep 24, 2026 | $2.2768 | $2.47 | $2.2768 | $2.44 | 20.65K |
| Sep 23, 2026 | $2.52 | $2.60 | $2.50 | $2.55 | 14.37K |
| Sep 22, 2026 | $2.38 | $2.65 | $2.2847 | $2.50 | 51.32K |
| Sep 21, 2026 | $2.48 | $2.54 | $2.145 | $2.31 | 70.84K |
Latest VRAX news
The latest Smart Investors Daily articles mentioning VRAX.
Stock researchResearch & News · News
Company
Market Activity
Research & News
Loading stock research…
